Europe Dental Bone Graft Substitutes Market

The Europe dental bone graft substitutes market is projected to reach USD 641.46 million by 2031 from USD 411.07 million in 2025, at a CAGR of 6.4% during the forecast period.

The European dental bone graft substitutes market is largely influenced by the region's aging population, which has led to increased prevalence of tooth loss, periodontal disease, and alveolar bone resorption. As a result, demand for bone regeneration in implant and periodontal procedures has increased. The adoption is also supported by the increased use of advanced biomaterials, such as synthetic grafts, xenografts, and bioactive composites, especially in Western and Northern Europe, where clinics place strong emphasis on predictable implant outcomes and long-term stability.

To know about the assumptions considered for the study download the pdf brochure

Nevertheless, the market expansion is limited by the high prices of premium bone graft substitute materials, which deter uptake among price-sensitive patients and smaller practices. Moreover, fragmented, country-specific reimbursement policies for bone grafting procedures continue to create uneven adoption patterns across European markets.;
The prominent players in the Europe dental bone graft substitutes market include Institut Straumann AG (Switzerland), Dentsply Sirona (US), Envista (US), Kuraray Co. Ltd. (Japan), Johnson & Johnson (US), Stryker Corporation (US), Medtronic, Plc (Ireland),  Zimvie Inc. (US), Henry Schein Inc. (US), and Integra Lifesciences Holdings Corporation (US).

• In January 2024, RTI Surgical (US) acquired ownership of Cook Biotech (US) to enhance the field of regenerative medicine and provide a broad range of allograft and xenograft biomaterials at a competitive price.
• In November 2023, Nobel Biocare (a subsidiary of Envista Holdings) launched its new product, creos syntogain, a biocompatible synthetic porous (bone) substitute with a multidirectional interconnected porous structure for use in periodontal, oral, and maxillofacial surgery.

MEDTRONIC PLC. (IRELAND)

Medtronic develops and manufactures healthcare technologies and therapies for a variety of medical conditions. Their product portfolio includes cardiac and vascular devices such as pacemakers, defibrillators, heart valves, stents, vascular access devices, and minimally invasive therapy devices, including surgical staplers, robotic surgical systems, ablation catheters, and neuromodulation devices. The neuromodulation devices include deep brain stimulation systems, spinal cord stimulation systems, and diabetes devices, including insulin pumps, continuous glucose monitoring systems, and medical-surgical devices such as spinal implants and surgical navigation systems.

KURARAY CO. LTD (JAPAN)

Kuraray is a leading innovator in specialty chemicals, synthetic fibers, and other materials. They have a long history of developing cutting-edge technologies, with their first success being the commercialization of synthetic rayon in 1926. Kuraray's product portfolio spans a wide range of materials used across industries such as automotive, healthcare, electronics, and environmental solutions. The company is committed to sustainability and incorporates it into its corporate philosophy. It focuses on developing eco-friendly products and processes to minimize the environmental impact.

HENRY SCHEIN, INC. (US)

Henry Schein is an American company and a Fortune World's Most Admired Company. It is the world's largest distributor of healthcare products and services, with a presence in 32 countries. The company supplies a wide range of medical, dental, and animal health products to office-based healthcare professionals. The company also offers practice management software, equipment financing, and other value-added services.

Related Reports:

Europe Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft,Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, And Country

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com